한글목차

세계의 말초혈관 기기 시장은 2025년에 135억 1,000만 달러로 추정되고, 2032년에는 210억 달러에 이를 것으로 예측되며, 2025년부터 2032년까지 연평균 성장률(CAGR) 6.5%로 성장할 전망입니다.

그림. 말초혈관 기기 지역별 시장 점유율(%)(2025년)

세계의 말초혈관 기기 시장은 노인 증가와 생활 습관병의 만연으로 최근 몇 년동안 안정된 성장을 이루고 있습니다. 말초혈관 기기는 주로 말초 동맥 질환(PAD)의 진단 및 치료에 사용되며 팔다리로의 혈류를 감소시키는 협착 동맥을 특징으로 하는 질병입니다. 약물 용출 스텐트 및 스코어링 풍선 카테터와 같은 첨단 기술 개발에 중점을 둔 연구 활동의 활성화는 예측 기간 동안 시장 확대에 긍정적인 영향을 미칠 것으로 예상됩니다. 선진 경제 국가에서 유리한 상환 시나리오 및 조기 진단에 대한 의식의 고조에 따라 시장 성장을 보완하고 있습니다. 그러나 특정 절차를 수반하는 고액의 치료비와 엄격한 규제 당국의 승인은 시장 성장을 방해하는 주요 요인 중 하나입니다.

시장 역학

세계의 말초혈관 기기 시장 성장은 만성 질환에 걸리기 쉬운 노인 증가, 말초 동맥 질환으로 이어지는 당뇨병과 비만 등 생활 습관병의 유병률 증가, 혁신적인 디바이스 개발을 위한 연구 개발의 활성화 등이 주요 요인입니다. 당뇨병 환자에서 PAD에 걸릴 위험의 높이는 효과적인 진단과 중재 기술의 필요성을 높이고 말초 혈관기구 수요에 박차를 가하고 있습니다. 그러나 기술적으로 첨단 장치와 치료법의 비용이 높고 신제품 승인을 위한 규제 시책이 어려운 것이 시장의 성장을 억제하는 큰 과제가 되고 있습니다. 한편, 생체 흡수성 스텐트 및 효율적인 약물 전달 시스템을 도입하기 위해 주요 기업이 착수하는 지속적인 연구개발 활동은 예측 기간 동안 시장 진출기업에게 유리한 기회를 제공합니다.

본 조사의 주요 특징

• 본 보고서에서는 세계의 말초혈관 기기 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모(10억 달러) 및 복합 연간 성장률(CAGR%)을 제공합니다.
• 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 행렬을 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 주요 인사이트도 제공합니다.
• 엔터프라이즈 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 매개변수를 기반으로 세계 말초혈관 기기 시장의 주요 기업을 프로파일링합니다.
• 이 보고서를 통해 인사이트는 마케팅 담당자와 기업 경영진이 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있도록 합니다.
• 세계의 말초혈관 기기 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통 업체, 신규 진출자, 재무 분석가 등이 산업의 다양한 이해 관계자를 지원합니다.
• 이해관계자들은 세계의 말초혈관 기기 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사 결정이 용이해집니다.

목차

제1장 조사의 목적 및 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의 및 범위
• 주요 요약
• Coherent Opportunity Map (COM)

제3장 시장 역학, 규제 및 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 시장 기회
• 영향 분석
• 시장 동향
• 인수 및 제휴 시나리오
• 기술 개요
• 규제 시나리오
• PEST 분석

제4장 세계의 말초혈관 기기 시장 : COVID-19 팬데믹의 영향

• 전체적인 영향
• 수요 및 공급에 미치는 영향
• 시장에 대한 COVID-19의 영향

제5장 세계의 말초혈관 기기 시장 : 제품 유형별(2020-2032년)(10억 달러)

• 서문
• 말초 혈관 스텐트
• 말초 혈관 성형술용 풍선 카테터
• PTA 가이드와이어
• 아테롬 절제 장치
• 만성 완전 폐색 장치
• 대동맥 스텐트
• 인공외과용 이식편
• 기타

제6장 세계의 말초혈관 기기 시장 : 최종 사용자별(2020-2032년)(10억 달러)

• 서문
• 병원
• 전문 클리닉
• 외래수술센터(ASC)
• 기타

제7장 세계의 말초혈관 기기 시장 : 지역별(2020-2032년)(10억 달러)

• 서문
• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제8장 경쟁 구도

• Abbot Laboratories
• Boston Scientific Corporation
• Angioscore
• Emboline Inc.
• Becton Dickinson, and Company
• Cook Group Inc.
• Cordis Corporation
• COVIDien PLC
• Edward Lifesciences Corporation
• Medtronic Plc
• St. Jude Medical
• Bayer AG
• Teleflex Medical
• Koninklijke Philips NV
• Cardio Flow, Inc.

제9장 분석가 시점

• 융성 및 쇠퇴
• 일관형 기회 맵

제10장 참고문헌 및 조사방법

• 참고문헌
• 조사방법

영문목차

Global Peripheral Vascular Devices Market is estimated to be valued at USD 13.51 Bn in 2025 and is expected to reach USD 21.00 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.

Figure. Peripheral Vascular Devices Market Share (%), By Region 2025

Global peripheral vascular devices market has been witnessing steady growth over the past few years owing to increasing geriatric population and prevalence of lifestyle diseases. Peripheral vascular devices are majorly used in diagnosis and treatment of peripheral artery disease (PAD), a condition characterized by narrowed arteries reducing blood flow to limbs. Rising research activities focusing on development of advanced technologies such as drug-eluting stents and scoring balloon catheters is expected to positively influence the market expansion during the forecast period. Favorable reimbursement scenario in developed economies and growing awareness regarding early diagnosis are supplementing the market growth. However, high cost of treatment accompanied with certain procedures and strict regulatory approvals are some of the major factors impeding the market growth.

Market Dynamics:

Global peripheral vascular devices market growth is primarily driven by increasing geriatric population prone to chronic diseases, growing prevalence of lifestyle diseases such as diabetes, obesity leading to peripheral artery disease as well as rising research initiatives for development of innovative devices. High risk of contracting PAD in diabetic patients boosts the need for effective diagnostic and interventional procedures, thereby, fueling demand for peripheral vascular devices. However, high cost of technologically advanced devices and treatment procedures along with stringent regulatory policies for new product approvals are major challenges restraining the market growth. Meanwhile, ongoing research & development activities embarked by key players to introduce bio-absorbable stents and efficient drug delivery systems present lucrative opportunities for market players over the forecast period.

Key Features of the Study:

• This report provides in-depth analysis of the global peripheral vascular devices market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global peripheral vascular devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study includes Abbott Laboratories, Boston Scientific Corporation, Angioscore, Emboline Inc., Becton Dickinson and Company, Cook Group Inc., Cordis Corporation, Covidien PLC, Edward Lifesciences Corporation, Medtronic Plc, St. Jude Medical, Bayer AG, Teleflex Medical, Koninklijke Philips N.V., and Cardio Flow, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global peripheral vascular devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peripheral vascular devices market.

Detailed Segmentation-

• Product Type:
  • Peripheral Vascular Stents
  • Peripheral Transluminal Angioplasty Balloon Catheters
  • PTA Guidewires
  • Atherectomy Devices
  • Chronic Total Occlusion Devices
  • Aortic Stents
  • Synthetic Surgical Grafts
  • Others
• End User:
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Angioscore
  • Emboline Inc.
  • Becton Dickinson and Company
  • Cook Group Inc.
  • Cordis Corporation
  • Covidien PLC
  • Edward Lifesciences Corporation
  • Medtronic Plc
  • Jude Medical
  • Bayer AG.
  • Teleflex Medical
  • Koninklijke Philips N.V.
  • Cardio Flow, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• PEST Analysis

4. Global Peripheral Vascular Devices Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Impact on Supply and Demand
• COVID-19 Impact on the market

5. Global Peripheral Vascular Devices Market, By Product Type, 2020 - 2032, (USD BN)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Peripheral Vascular Stents
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Peripheral Transluminal Angioplasty Balloon Catheters
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• PTA Guidewires
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Atherectomy Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Chronic Total Occlusion Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Aortic Stents
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Synthetic Surgical Grafts
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

6. Global Peripheral Vascular Devices Market, By End User, 2020 - 2032, (USD BN)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Specialty Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Ambulatory Surgical Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

7. Global Peripheral Vascular Devices Market, By Region, 2020 - 2032, (USD BN)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD BN)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

• Abbot Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Angioscore
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Emboline Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Becton Dickinson, and Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Cook Group Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Cordis Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Covidien PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Edward Lifesciences Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Medtronic Plc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• St. Jude Medical
• Bayer AG
• Teleflex Medical
• Koninklijke Philips N.V.
• Cardio Flow, Inc.

9. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact

"